Distribution patterns of 21-gene recurrence score in 980 Chinese estrogen receptor-positive, HER2-negative early breast cancer patients. Jiayi Wu, Yan Fang, +11 authors, Lin Lin, Xiaochun Fei, Weiqi Gao, Siji Zhu, Yu Zong, Xiaosong Chen, Ou Huang, Jianrong He, Li Zhu, Weiguo Chen, Yafen Li, Kunwei Shen. less Oncotarget, 2017 Apr 14; 8(24). PMID: 28404972 Free PMC article.
|
NCCN Guidelines Insights: Breast Cancer, Version 3.2018. Matthew P Goetz, William J Gradishar, +30 authors, Benjamin O Anderson, Jame Abraham, Rebecca Aft, Kimberly H Allison, Sarah L Blair, Harold J Burstein, Chau Dang, Anthony D Elias, William B Farrar, Sharon H Giordano, Lori J Goldstein, Steven J Isakoff, Janice Lyons, P Kelly Marcom, Ingrid A Mayer, Meena S Moran, Joanne Mortimer, Ruth M O'Regan, Sameer A Patel, Lori J Pierce, Elizabeth C Reed, Hope S Rugo, Amy Sitapati, Karen Lisa Smith, Mary Lou Smith, Hatem Soliman, Melinda L Telli, John H Ward, Jessica S Young, Dorothy A Shead, Rashmi Kumar. less J Natl Compr Canc Netw, 2019 Feb 23; 17(2). PMID: 30787125 Highly Cited.
|
Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study. Valentina I Petkov, Dave P Miller, +21 authors, Nadia Howlader, Nathan Gliner, Will Howe, Nicola Schussler, Kathleen Cronin, Frederick L Baehner, Rosemary Cress, Dennis Deapen, Sally L Glaser, Brenda Y Hernandez, Charles F Lynch, Lloyd Mueller, Ann G Schwartz, Stephen M Schwartz, Antoinette Stroup, Carol Sweeney, Thomas C Tucker, Kevin C Ward, Charles Wiggins, Xiao-Cheng Wu, Lynne Penberthy, Steven Shak. less NPJ Breast Cancer, 2017 Jul 20; 2. PMID: 28721379 Free PMC article. Highly Cited.
|
West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment. Oleg Gluz, Ulrike A Nitz, +18 authors, Matthias Christgen, Ronald E Kates, Steven Shak, Michael Clemens, Stefan Kraemer, Bahriye Aktas, Sherko Kuemmel, Toralf Reimer, Manfred Kusche, Volker Heyl, Fatemeh Lorenz-Salehi, Marianne Just, Daniel Hofmann, Tom Degenhardt, Cornelia Liedtke, Christer Svedman, Rachel Wuerstlein, Hans H Kreipe, Nadia Harbeck. less J Clin Oncol, 2016 Mar 02; 34(20). PMID: 26926676 Highly Cited.
|
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), R Peto, +15 authors, C Davies, J Godwin, R Gray, H C Pan, M Clarke, D Cutter, S Darby, P McGale, C Taylor, Y C Wang, J Bergh, A Di Leo, K Albain, S Swain, M Piccart, K Pritchard. less Lancet, 2011 Dec 14; 379(9814). PMID: 22152853 Free PMC article. Highly Cited.
|
Clinical utility of gene-expression signatures in early stage breast cancer. Maryann Kwa, Andreas Makris, Francisco J Esteva. Nat Rev Clin Oncol, 2017 Jun 01; 14(10). PMID: 28561071 Highly Cited. Review.
|
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Lancet, 2005 May 17; 365(9472). PMID: 15894097 Highly Cited.
|
Tumor grade and progesterone receptor status predict 21-gene recurrence score in early stage invasive breast carcinoma. Jing Li Huang, Scott Kizy, +5 authors, Schelomo Marmor, Ariella Altman, Anne Blaes, Heather Beckwith, Todd M Tuttle, Jane Yuet Ching Hui. less Breast Cancer Res Treat, 2018 Sep 10; 172(3). PMID: 30196425
|
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial. Joseph A Sparano, Robert J Gray, +26 authors, Della F Makower, Kathy S Albain, Thomas J Saphner, Sunil S Badve, Lynne I Wagner, Virginia G Kaklamani, Maccon M Keane, Henry L Gomez, Pavan S Reddy, Timothy F Goggins, Ingrid A Mayer, Deborah L Toppmeyer, Adam M Brufsky, Matthew P Goetz, Jeffrey L Berenberg, Catalin Mahalcioiu, Christine Desbiens, Daniel F Hayes, Elizabeth C Dees, Charles E Geyer, John A Olson, William C Wood, Tracy Lively, Soonmyung Paik, Matthew J Ellis, Jeffrey Abrams, George W Sledge. less JAMA Oncol, 2019 Oct 01; 6(3). PMID: 31566680 Free PMC article.
|
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer. Joseph A Sparano, Robert J Gray, +27 authors, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Daniel F Hayes, Charles E Geyer, Elizabeth C Dees, Matthew P Goetz, John A Olson, Tracy Lively, Sunil S Badve, Thomas J Saphner, Lynne I Wagner, Timothy J Whelan, Matthew J Ellis, Soonmyung Paik, William C Wood, Peter M Ravdin, Maccon M Keane, Henry L Gomez Moreno, Pavan S Reddy, Timothy F Goggins, Ingrid A Mayer, Adam M Brufsky, Deborah L Toppmeyer, Virginia G Kaklamani, Jeffrey L Berenberg, Jeffrey Abrams, George W Sledge. less N Engl J Med, 2018 Jun 05; 379(2). PMID: 29860917 Free PMC article. Highly Cited.
|
Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor-Positive Early Breast Cancer: Results of a Prospective Cohort Study. Anne Kuijer, Marieke Straver, +8 authors, Bianca den Dekker, Annelotte C M van Bommel, Sjoerd G Elias, Carolien H Smorenburg, Jelle Wesseling, Sabine C Linn, Emiel J Th Rutgers, Sabine Siesling, Thijs van Dalen. less J Clin Oncol, 2017 Aug 17; 35(24). PMID: 28813638
|
Pooled analysis of prospective European studies assessing the impact of using the 21-gene Recurrence Score assay on clinical decision making in women with oestrogen receptor-positive, human epidermal growth factor receptor 2-negative early-stage breast cancer. Joan Albanell, Christer Svedman, +6 authors, Joseph Gligorov, Simon D H Holt, Gianfilippo Bertelli, Jens-Uwe Blohmer, Roman Rouzier, Ana Lluch, Wolfgang Eiermann. less Eur J Cancer, 2016 Aug 22; 66. PMID: 27544930
|
Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry. Salomon M Stemmer, Mariana Steiner, +21 authors, Shulamith Rizel, Lior Soussan-Gutman, Noa Ben-Baruch, Avital Bareket-Samish, David B Geffen, Bella Nisenbaum, Kevin Isaacs, Georgeta Fried, Ora Rosengarten, Beatrice Uziely, Christer Svedman, Debbie McCullough, Tara Maddala, Shmuel H Klang, Jamal Zidan, Larisa Ryvo, Bella Kaufman, Ella Evron, Natalya Karminsky, Hadassah Goldberg, Steven Shak, Nicky Liebermann. less NPJ Breast Cancer, 2017 Sep 14; 3. PMID: 28900633 Free PMC article.
|
21-Gene recurrence score decreases receipt of chemotherapy in ER+ early-stage breast cancer: an analysis of the NCDB 2010-2013. Benjamin M Parsons, Jeffrey Landercasper, +3 authors, Angela L Smith, Ronald S Go, Andrew J Borgert, Leah L Dietrich. less Breast Cancer Res Treat, 2016 Aug 11; 159(2). PMID: 27507245 Free PMC article.
|
Community clinical practice patterns and mortality in patients with intermediate oncotype DX recurrence scores: Who benefits from chemotherapy? Abiola F Ibraheem, David J Press, Olufunmilayo I Olopade, Dezheng Huo. Cancer, 2018 Nov 06; 125(2). PMID: 30387876 Free PMC article.
|
The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis. Josh J Carlson, Joshua A Roth. Breast Cancer Res Treat, 2013 Aug 27; 141(1). PMID: 23974828 Free PMC article. Highly Cited. Systematic Review.
|
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. Soonmyung Paik, Steven Shak, +12 authors, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park, William Hiller, Edwin R Fisher, D Lawrence Wickerham, John Bryant, Norman Wolmark. less N Engl J Med, 2004 Dec 14; 351(27). PMID: 15591335 Highly Cited.
|
21-Gene Recurrence Score Assay As a Predictor of Adjuvant Chemotherapy Administration for Early-Stage Breast Cancer: An Analysis of Use, Therapeutic Implications, and Disparity Profile. Jagar Jasem, Arya Amini, +4 authors, Rachel Rabinovitch, Virginia F Borges, Anthony Elias, Christine M Fisher, Peter Kabos. less J Clin Oncol, 2016 Mar 24; 34(17). PMID: 27001563 Free PMC article.
|
Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26-30. Seho Park, Yunan Han, +7 authors, Ying Liu, Adetunji T Toriola, Lindsay L Peterson, Graham A Colditz, Seung Il Kim, Young Up Cho, Byeong-Woo Park, Yikyung Park. less Breast Cancer Res, 2019 Oct 18; 21(1). PMID: 31619259 Free PMC article.
|
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. A Goldhirsch, E P Winer, +5 authors, A S Coates, R D Gelber, M Piccart-Gebhart, B Thürlimann, H-J Senn, Panel members. less Ann Oncol, 2013 Aug 07; 24(9). PMID: 23917950 Free PMC article. Highly Cited.
|
High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial. Torsten O Nielsen, Maj-Brit Jensen, +4 authors, Samantha Burugu, Dongxia Gao, Charlotte L Tykjaer Jørgensen, Eva Balslev, Bent Ejlertsen. less Clin Cancer Res, 2016 Sep 08; 23(4). PMID: 27601592
|
Is Age Trumping Genetic Profiling in Clinical Practice? Relationship of Chemotherapy Recommendation and Oncotype DX Recurrence Score in Patients Aged < 50 Years versus ≥ 50 Years, and Trends Over Time. Austin D Williams, Sylvia A Reyes, +2 authors, Renee L Arlow, Julia Tchou, Lucy M De La Cruz. less Ann Surg Oncol, 2018 Jul 01; 25(10). PMID: 29959613
|
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. Soonmyung Paik, Gong Tang, +11 authors, Steven Shak, Chungyeul Kim, Joffre Baker, Wanseop Kim, Maureen Cronin, Frederick L Baehner, Drew Watson, John Bryant, Joseph P Costantino, Charles E Geyer, D Lawrence Wickerham, Norman Wolmark. less J Clin Oncol, 2006 May 25; 24(23). PMID: 16720680 Highly Cited.
|
Relationship of histologic grade and histologic subtype with oncotype Dx recurrence score; retrospective review of 863 breast cancer oncotype Dx results. Kamaljeet Singh, Xin He, +3 authors, Elizabeth T Kalife, Shahrzad Ehdaivand, Yihong Wang, C James Sung. less Breast Cancer Res Treat, 2017 Dec 13; 168(1). PMID: 29230662
|
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer. Joseph A Sparano, Robert J Gray, +28 authors, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Daniel F Hayes, Charles E Geyer, Elizabeth C Dees, Edith A Perez, John A Olson, JoAnne Zujewski, Tracy Lively, Sunil S Badve, Thomas J Saphner, Lynne I Wagner, Timothy J Whelan, Matthew J Ellis, Soonmyung Paik, William C Wood, Peter Ravdin, Maccon M Keane, Henry L Gomez Moreno, Pavan S Reddy, Timothy F Goggins, Ingrid A Mayer, Adam M Brufsky, Deborah L Toppmeyer, Virginia G Kaklamani, James N Atkins, Jeffrey L Berenberg, George W Sledge. less N Engl J Med, 2015 Sep 29; 373(21). PMID: 26412349 Free PMC article. Highly Cited.
|
Association of 70-Gene Signature Assay Findings With Physicians' Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay. Michaela Tsai, Shelly Lo, +11 authors, William Audeh, Rubina Qamar, Raye Budway, Ellis Levine, Pat Whitworth, Blanche Mavromatis, Robin Zon, Dwight Oldham, Sarah Untch, Tina Treece, Lisa Blumencranz, Hatem Soliman. less JAMA Oncol, 2017 Oct 28; 4(1). PMID: 29075751 Free PMC article.
|
A nomogram to predict adjuvant chemotherapy recommendation in breast cancer patients with intermediate recurrence score. Feilin Qu, Xiaosong Chen, +10 authors, Xiaochun Fei, Lin Lin, Weiqi Gao, Yu Zong, Jiayi Wu, Ou Huang, Jianrong He, Li Zhu, Weiguo Chen, Yafen Li, Kunwei Shen. less Chin J Cancer Res, 2018 Jun 05; 30(2). PMID: 29861607 Free PMC article.
|
The impact of the 21-gene assay on adjuvant treatment decisions in oestrogen receptor-positive early breast cancer: a prospective study. Anna Kuchel, Tim Robinson, +8 authors, Charles Comins, Mike Shere, Mohini Varughese, Geoff Sparrow, Ajay Sahu, Louise Saunders, Amit Bahl, Simon J Cawthorn, Jeremy P Braybrooke. less Br J Cancer, 2016 Mar 10; 114(7). PMID: 26954715 Free PMC article.
|
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer. Joseph A Sparano, Robert J Gray, +27 authors, Peter M Ravdin, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Daniel F Hayes, Charles E Geyer, Elizabeth C Dees, Matthew P Goetz, John A Olson, Tracy Lively, Sunil S Badve, Thomas J Saphner, Lynne I Wagner, Timothy J Whelan, Matthew J Ellis, Soonmyung Paik, William C Wood, Maccon M Keane, Henry L Gomez Moreno, Pavan S Reddy, Timothy F Goggins, Ingrid A Mayer, Adam M Brufsky, Deborah L Toppmeyer, Virginia G Kaklamani, Jeffrey L Berenberg, Jeffrey Abrams, George W Sledge. less N Engl J Med, 2019 Jun 04; 380(25). PMID: 31157962 Free PMC article. Highly Cited.
|
Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis. Amila Orucevic, Robert E Heidel, John L Bell. Breast Cancer Res Treat, 2016 May 22; 157(3). PMID: 27206678 Free PMC article.
|
Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features. Lori J Goldstein, Robert Gray, +12 authors, Sunil Badve, Barrett H Childs, Carl Yoshizawa, Steve Rowley, Steven Shak, Frederick L Baehner, Peter M Ravdin, Nancy E Davidson, George W Sledge, Edith A Perez, Lawrence N Shulman, Silvana Martino, Joseph A Sparano. less J Clin Oncol, 2008 Aug 06; 26(25). PMID: 18678838 Free PMC article. Highly Cited.
|
Global cancer statistics, 2012. Lindsey A Torre, Freddie Bray, +3 authors, Rebecca L Siegel, Jacques Ferlay, Joannie Lortet-Tieulent, Ahmedin Jemal. less CA Cancer J Clin, 2015 Feb 06; 65(2). PMID: 25651787 Highly Cited.
|
Statistics for surgeons - understanding survival analysis. Girdhar Gopal Agarwal. Indian J Surg Oncol, 2013 Sep 03; 3(3). PMID: 23997508 Free PMC article.
|
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Kathy S Albain, William E Barlow, +20 authors, Steven Shak, Gabriel N Hortobagyi, Robert B Livingston, I-Tien Yeh, Peter Ravdin, Roberto Bugarini, Frederick L Baehner, Nancy E Davidson, George W Sledge, Eric P Winer, Clifford Hudis, James N Ingle, Edith A Perez, Kathleen I Pritchard, Lois Shepherd, Julie R Gralow, Carl Yoshizawa, D Craig Allred, C Kent Osborne, Daniel F Hayes, Breast Cancer Intergroup of North America. less Lancet Oncol, 2009 Dec 17; 11(1). PMID: 20005174 Free PMC article. Highly Cited.
|
Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario. Mark N Levine, Jim A Julian, +5 authors, Philippe L Bedard, Andrea Eisen, Maureen E Trudeau, Brian Higgins, Louise Bordeleau, Kathleen I Pritchard. less J Clin Oncol, 2015 Nov 26; 34(10). PMID: 26598746
|